Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-8221117

  • Global Fluoroscopy Equipment Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: November 2017 | Report Code: HME-8221117

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Fluoroscopy equipment is a kind of medical imaging equipment that displays a continuous X-ray image on a monitor, much like an X-ray movie. It uses X-rays to attain real time moving images of the inside of an object, just like X-ray computed tomography and radiography  It is a generally used medical technique that aids physicians with an extensive variety of interventional procedures and diagnostic. Fluoroscopy equipment is majorly used for the imaging of gastrointestinal tract to analyse the clinical conditions such as ulcers, tumours, blockades and inflammation etc. in addition to this, it is used to monitor the procedures such as venography, orthopedic surgeries, angiography, which require radiological intervention. The global fluoroscopy equipment market is anticipated to be grow with a CAGR of around 4.9% during the forecast period (2016-2023).The advancement in fluoroscopy technology such as digital image processing and flat panel detector is primarily trending in the market, which results in much lower radiation doses than conventional procedures. Recently in the year 2017, Agfa HealthCare launches a new DR 800 multipurpose digital imaging system for dynamic image processing. The DR 800 delivers fluoroscopy, radiography and advanced clinical applications.

The major driving factor of the global fluoroscopy equipment market is increasing number of interventional radiology procedures, growing minimally invasive procedures, increasing geriatric population and increasing prevalence of CVD.  However, minimally invasive surgery is a mounting field in medicine. Procedures such as angioplasty, coronary angiography, and stent placement depends profoundly on the usage of fluoroscopy to visually direct the surgeon accomplishing the procedure. Annually, large number of fluoroscopic procedures are done in the united states. This quantity is only rising due to the minimally invasive surgery expertise advances. The minimally invasive interventions offer a safer, better, and cheaper solution when it is associated to open surgery. According to the annual plastic surgery procedural statistics, in 2015 around 15.9 million minimally-invasive cosmetic and surgical procedures were made in the United States, which is a 2 % increase over 2014. Furthermore, in the year 2016 around 17.1 million surgical and minimally-invasive cosmetic procedures were performed. Generally, Fluoroscopy is employed to direct minimally invasive surgical interventions somewhere tools or catheters, are injected percutaneously to treat and diagnose internal organs.

Source: OBRC Analysis.

The report on global Fluoroscopy Equipment market includes product and applications.

Product is segmented into:

  • Fixed Fluoroscopy Equipment
  • C-Arms



The applications of Fluoroscopy Equipment include:

  • Orthopedic
  • Pain Management & Trauma
  • Cardiovascular
  • Neurology
  • Gastrointestinal
  • General Surgery
  • Urology
  • Others









The report scope is widely categorized on the basis of its product which includesFixed Fluoroscopy Equipment and C-Arms. Moreover, the market revenue estimates and forecast includes hardware systems. However, software is excluded from the market.

The global Fluoroscopy Equipment market report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America accounts highest revenue share in 2016. The highest share of this segment can mainly be accredited to the growing incidence of overuse sports injuries, increasing prevalence of CVDs (cardiovascular diseases) and growing number of knee and hip replacement surgeries in the country. According to the American Academy of Orthopedic Surgeons, over 7 million Americans are living with an artificial (prosthetic) hip with around 2.5 million andaround 4.7 million with knee. Around 1.5 % of Americans are living with knee replacement and 0.8 % with a hip replacement.  Enforcement of strict reimbursement and regulatory framework motivated to safeguard patient safety & high diagnostic standards are expected to drive the demand in North America. Asia Pacific is anticipated to grow with a highest CAGR during the forecast period. Developing economies in the region, such as China and India, are observing robust economic growth. Growing healthcare expenditure and Increasing prevalence of diseases have prompted the demand for advanced diagnostics across this region. Healthcare market of China is growing impressively Due to the annual expenditure of China’s healthcare system is anticipated to reach $894 billion by 2019 from $575 billion in 2014.

Global fluoroscopy equipment market report covers segmentation analysis of product and application. Report further covers segments of products which includes fixed fluoroscopy equipment and C-arms. Fixed fluoroscopy equipment segment holds the highest revenue share in product segment, due to the importance of usage in extensive array of procedures for example angiography, image-guided biopsy, discography and growing usage of fluoroscopes in formerly new applications. Benefits associated with fixed fluoroscopy equipment such as radiation sensitivity, X-ray recording capability optical magnification, lower levels of scattered radiation and high portability are accountable for it developing as the dominant segment. The C-arms segment is anticipated to grow with a highest CAGR during the forecast period. The high growth of C-arms segment can be accredited to the growing demand for minimally invasive procedures and the advantages offered by C-arms such as user-friendliness in surgical procedures and lower radiation dose as compared to fixed fluoroscopy equipment.

The major market players of the global fluoroscopy equipment market are:

  • Siemens AG
  • Ziehm Imaging GmbH
  • Koninklijke Philips N.V.
  • Shimadzu Corporation
  • GE Healthcare
  • Toshiba Medical Systems Corporation
  • Hitachi, Ltd.
  • Others









These companies using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, merger & acquisition is the key strategy adopted by the companies in the fluoroscopy equipment market.

For example: in year 2016 Carestream Health has announced two new fluoroscopy and radiography systems such as DRX-Excel Plus and DRX-Excel that are considered to deliver high-quality, cost-effective imaging. The systems perform contrast exams and improve workflow using fluoroscopy that can be related with a radiography image.

In year 2015, Toshiba America Medical Systems strategy was to introduce Ultimax-i FPD, a novel multipurpose fluoroscopy/radiography system which is designed to increase the capabilities of angiography labs.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in fluoroscopy equipment market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023
  • Report includes detailed analysis of different segments such as product and applications of fluoroscopy equipment.
  • Identify and understand the strength, opportunities, challenges and threat of the fluoroscopy equipment market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, competitive landscape analysis of major players of fluoroscopy segment market.
  • Detailed analysis of various the regulatory policies which are affecting the global fluoroscopy equipment market.






How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global fluoroscopy equipment market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the fluoroscopy equipment market, with giving extensive SCOT analysis of key companies. 

Key findings of the global fluoroscopy equipment market:

  • Growing demand for minimally invasive procedures is adding growth in global Air purifiers market.
  • North America held highest revenue share in 2016.
  • Fixed fluoroscopy equipment segment held the large revenue share in 2016.
  • Product Launch is the key strategy adopted by players of fluoroscopy equipment market.  
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL FLUOROSCOPY EQUIPMENT MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. INCREASING NUMBER OF INTERVENTIONAL RADIOLOGY PROCEDURES
3.1.2. GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
3.1.3. INCREASING GERIATRIC POPULATION
3.1.4. INCREASING PREVALENCE OF CVD
3.2. MARKET RESTRAINTS
3.2.1. RADIATION EXPOSURE
3.2.2. STRINGENT REGULATORY PROCESS
3.3. MARKET OPPORTUNITIES
3.3.1. GROWING DEMAND FOR DATA-INTEGRATED IMAGING SYSTEMS
3.3.2. GROWING HEALTHCARE EXPENDITURE
3.4.   MARKET CHALLENGES 
3.4.1. ACCESSIBILITY OF BETTER SUBSTITUTES
3.4.2. HIGH COST CONCERN RELATED TO FLUOROSCOPY EQUIPMENT
 
4. MARKET SEGMENTATION 
4.1. GLOBAL FLUOROSCOPY EQUIPMENT MARKET BY PRODUCT
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL FIXED FLUOROSCOPY EQUIPMENT MARKET 
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL C-ARMS MARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.2. GLOBAL FLUOROSCOPY EQUIPMENT MARKET BY APPLICATION
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL ORTHOPAEDIC MARKET 
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL PAIN MANAGEMENT & TRAUMA MARKET 
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBAL CARDIOVASCULAR MARKET 
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.4. KEY CONCLUSIONS
4.2.5.4. GLOBAL NEUROLOGY MARKET 
4.2.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.4. KEY CONCLUSIONS
4.2.5.5. GLOBAL UROLOGY MARKET 
4.2.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.5.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.4. KEY CONCLUSIONS
4.2.5.6. GLOBAL GASTROINTESTINAL MARKET 
4.2.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.6.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.6.4. KEY CONCLUSIONS
4.2.5.7. GLOBAL GENERAL SURGERY MARKET 
4.2.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.7.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.7.4. KEY CONCLUSIONS
4.2.5.8. GLOBAL OTHERS MARKET 
4.2.5.8.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.8.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.8.3. TOP PLAYERS & KEY PRODUCTS
4.2.5.8.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION 
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GLOBAL FLUOROSCOPY EQUIPMENT MARKET BY REGION 
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. ITALY 
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ADANI SYSTEMS, INC. (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. AGFA-GEVAERT GROUP. (BELGIUM.)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. ALLENGERS MEDICAL SYSTEMS (INDIA.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. CARESTREAM HEALTH, INC (U.S.) 
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. GE HEALTHCARE (U.K.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. HITACHI, LTD. (TOKYO)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.6.5. STRATEGIC ANALYSIS
7.7. HOLOGIC, INC (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. KONINKLIJKE PHILIPS N.V. (NETHERLAND)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.8.5. STRATEGIC ANALYSIS
7.9. LEPU MEDICAL TECHNOLOGY CO., LTD. (CHINA.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. ORTHOSCAN, INC (ARIZONA.)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. SIEMENS HEALTHCARE (GERMANY)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. SHIMADZU CORPORATION (JAPAN)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. TOSHIBA MEDICAL SYSTEMS CORPORATION(JAPAN)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. VARIAN MEDICAL SYSTEMS(U.S)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. ZIEHM IMAGING (GERMANY)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL FLUOROSCOPY EQUIPMENTMARKET BY PRODUCT 2014-2023($ MILLION)
2. GLOBAL FIXED FLUOROSCOPY EQUIPMENT MARKET BY GEOGRAPHY 2014-2023($ MILLION)
3. GLOBAL C-ARMS MARKET BY GEOGRAPHY 2014-2023($ MILLION)
4. GLOBAL FLUOROSCOPY EQUIPMENT MARKET BY APPLICATION 2014-2023($ MILLION)
5. GLOBAL ORTHOPEDIC MARKET BY GEOGRAPHY 2014-2023($ MILLION)
6. GLOBAL PAIN MANAGEMENT & TRAUMA MARKET BY GEOGRAPHY 2014-2023($ MILLION)
7. GLOBAL CARDIOVASCULAR MARKET BY GEOGRAPHY 2014-2023($ MILLION)
8. GLOBAL NEUROLOGY MARKET BY GEOGRAPHY 2014-2023($ MILLION)
9. GLOBAL GASTROINTESTINAL MARKETBY GEOGRAPHY 2014-2023($ MILLION)
10. GLOBAL UROLOGY MARKET BY GEOGRAPHY 2014-2023($ MILLION)
11. GLOBAL GENERAL SURGERY MARKET BY GEOGRAPHY 2014-2023($ MILLION)
12. GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023($ MILLION)
13. NORTH AMERICA FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
14. EUROPE FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
15. ASIA PACIFIC FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
16. REST OF THE WORLD FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
 
LIST OF FIGURES
 
1. GLOBAL FIXED FLUOROSCOPY EQUIPMENT MARKET 2014-2023 ($ MILLION)
2. GLOBAL C-ARMS MARKET 2014-2023 ($ MILLION)
3. GLOBAL ORTHOPAEDIC MARKET 2014-2023 ($ MILLION)
4. GLOBAL PAIN MANAGEMENT & TRAUMA MARKET 2014-2023 ($ MILLION)
5. GLOBAL CARDIOVASCULAR MARKET 2014-2023 ($ MILLION)
6. GLOBAL NEUROLOGY MARKET 2014-2023 ($ MILLION)
7. GLOBAL GASTROINTESTINAL MARKET 2014-2023 ($ MILLION)
8. GLOBAL UROLOGY MARKET 2014-2023 ($ MILLION)
9. GLOBAL GENERAL SURGERY MARKET 2014-2023 ($ MILLION)
10. GLOBAL OTHERS MARKET 2014-2023 ($ MILLION)
11. UNITED STATES (U.S.) FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
12. CANADA FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
13. UNITED KINGDOM (UK) FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
14. FRANCE FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
15. GERMANY FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
16. SPAIN FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
17. ITALY FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
18. ROE FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
19. INDIA FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
20. CHINA FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
21. JAPAN FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
22. KOREA FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
23. AUSTRALIA FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
24. ROW APAC FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
25. LATIN AMERICA FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
26. MENA FLUOROSCOPY EQUIPMENT MARKET2014-2023 ($MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion